References
Schrauwen, W., Van de Cavey, J., Vingerhoets, G., Vanheule, S., Van den Broecke, R. and Denys, H. (2020) Heterogeneous Response of Chemotherapy-Related Cognitive Decline in Patients with Breast Cancer: A Prospective Study. Journal of the International Neuropsychological Society, 26, 806-814. >https://doi.org/10.1017/s1355617720000296
Loh, K.P., Janelsins, M.C., Mohile, S.G., Holmes, H.M., Hsu, T., Inouye, S.K., et al. (2016) Chemotherapy-Related Cognitive Impairment in Older Patients with Cancer. Journal of Geriatric Oncology, 7, 270-280. >https://doi.org/10.1016/j.jgo.2016.04.008
Biglia, N., Bounous, V.E., Malabaila, A., Palmisano, D., Torta, D.M.E., D’alonzo, M., et al. (2011) Objective and Self-Reported Cognitive Dysfunction in Breast Cancer Women Treated with Chemotherapy: A Prospective Study. European Journal of Cancer Care, 21, 485-492. >https://doi.org/10.1111/j.1365-2354.2011.01320.x
Bender, C.M., Sereika, S.M., Berga, S.L., Vogel, V.G., Brufsky, A.M., Paraska, K.K., et al. (2005) Cognitive Impairment Associated with Adjuvant Therapy in Breast Cancer. Psycho-Oncology, 15, 422-430. >https://doi.org/10.1002/pon.964
Amani, O., Mazaheri, M.A., Moghani, M.M., Zarani, F. and Choolabi, R.H. (2024) Chemotherapy-Induced Cognitive Impairment in Breast Cancer Survivors: A Systematic Review of Studies from 2000 to 2021. Cancer Reports, 7, e1989. >https://doi.org/10.1002/cnr2.1989
Wefel, J.S., Kesler, S.R., Noll, K.R. and Schagen, S.B. (2014) Clinical Characteristics, Pathophysiology, and Management of Noncentral Nervous System Cancer-Related Cognitive Impairment in Adults. CA: A Cancer Journal for Clinicians, 65, 123-138. >https://doi.org/10.3322/caac.21258
Janelsins, M.C., Kohli, S., Mohile, S.G., Usuki, K., Ahles, T.A. and Morrow, G.R. (2011) An Update on Cancer and Chemotherapy-Related Cognitive Dysfunction: Current Status. Seminars in Oncology, 38, 431-438. >https://doi.org/10.1053/j.seminoncol.2011.03.014
Koppelmans, V., Breteler, M.M.B., Boogerd, W., Seynaeve, C., Gundy, C. and Schagen, S.B. (2012) Neuropsychological Performance in Survivors of Breast Cancer More than 20 Years after Adjuvant Chemotherapy. Journal of Clinical Oncology, 30, 1080-1086. >https://doi.org/10.1200/jco.2011.37.0189
Bai, L. and Yu, E. (2021) A Narrative Review of Risk Factors and Interventions for Cancer-Related Cognitive Impairment. Annals of Translational Medicine, 9, 72-72. >https://doi.org/10.21037/atm-20-6443
Boykoff, N., Moieni, M. and Subramanian, S.K. (2009) Confronting Chemobrain: An In-Depth Look at Survivors’ Reports of Impact on Work, Social Networks, and Health Care Response. Journal of Cancer Survivorship, 3, 223-232. >https://doi.org/10.1007/s11764-009-0098-x
Myers, J.S. (2011) Chemotherapy-Related Cognitive Impairment: The Breast Cancer Experience. Oncology Nursing Forum, 39, E31-E40. >https://doi.org/10.1188/12.onf.e31-e40
Bolton, G. and Isaacs, A. (2018) Women’s Experiences of Cancer-Related Cognitive Impairment, Its Impact on Daily Life and Care Received for It Following Treatment for Breast Cancer. Psychology, Health&Medicine, 23, 1261-1274. >https://doi.org/10.1080/13548506.2018.1500023
Lv, L., Mao, S., Dong, H., Hu, P. and Dong, R. (2020) Pathogenesis, Assessments, and Management of Chemotherapy-Related Cognitive Impairment (CRCI): An Updated Literature Review. Journal of Oncology, 2020, 1-11. >https://doi.org/10.1155/2020/3942439
Lomeli, N., Di, K., Czerniawski, J., Guzowski, J.F. and Bota, D.A. (2017) Cisplatin-Induced Mitochondrial Dysfunction Is Associated with Impaired Cognitive Function in Rats. Free Radical Biology and Medicine, 102, 274-286. >https://doi.org/10.1016/j.freeradbiomed.2016.11.046
Sofis, M.J., Jarmolowicz, D.P., Kaplan, S.V., Gehringer, R.C., Lemley, S.M., Garg, G., et al. (2017) KU32 Prevents 5-Fluorouracil Induced Cognitive Impairment. Behavioural Brain Research, 329, 186-190. >https://doi.org/10.1016/j.bbr.2017.03.042
Ren, X., St. Clair, D.K. and Butterfield, D.A. (2017) Dysregulation of Cytokine Mediated Chemotherapy Induced Cognitive Impairment. Pharmacological Research, 117, 267-273. >https://doi.org/10.1016/j.phrs.2017.01.001
Lange, M., Joly, F., Vardy, J., Ahles, T., Dubois, M., Tron, L., et al. (2019) Cancer-Related Cognitive Impairment: An Update on State of the Art, Detection, and Management Strategies in Cancer Survivors. Annals of Oncology, 30, 1925-1940. >https://doi.org/10.1093/annonc/mdz410
Karschnia, P., Parsons, M.W. and Dietrich, J. (2019) Pharmacologic Management of Cognitive Impairment Induced by Cancer Therapy. The Lancet Oncology, 20, e92-e102. >https://doi.org/10.1016/s1470-2045(18)30938-0
Miladi, N., Dossa, R., Dogba, M.J., Cléophat-Jolicoeur, M.I.F. and Gagnon, B. (2019) Psychostimulants for Cancer-Related Cognitive Impairment in Adult Cancer Survivors: A Systematic Review and Meta-Analysis. Supportive Care in Cancer, 27, 3717-3727. >https://doi.org/10.1007/s00520-019-04907-w
Lawrence, J.A., Griffin, L., Balcueva, E.P., Groteluschen, D.L., Samuel, T.A., Lesser, G.J., et al. (2015) A Study of Donepezil in Female Breast Cancer Survivors with Self-Reported Cognitive Dysfunction 1 to 5 Years Following Adjuvant Chemotherapy. Journal of Cancer Survivorship, 10, 176-184. >https://doi.org/10.1007/s11764-015-0463-x
Rapp, S.R., Dressler, E.V., Brown, W.M., Wade, J.L., Le-Lindqwister, N., King, D., et al. (2024) Phase III Randomized, Placebo-Controlled Clinical Trial of Donepezil for Treatment of Cognitive Impairment in Breast Cancer Survivors after Adjuvant Chemotherapy (WF-97116). Journal of Clinical Oncology, 42, 2546-2557.>https://doi.org/10.1200/jco.23.01100
Winocur, G., Binns, M.A. and Tannock, I. (2011) Donepezil Reduces Cognitive Impairment Associated with Anti-Cancer Drugs in a Mouse Model. Neuropharmacology, 61, 1222-1228. >https://doi.org/10.1016/j.neuropharm.2011.07.013
Lim, I., Joung, H., Yu, A.R., Shim, I. and Kim, J.S. (2016) PET Evidence of the Effect of Donepezil on Cognitive Performance in an Animal Model of Chemobrain. BioMed Research International, 2016, 1-7. >https://doi.org/10.1155/2016/6945415
Sung, P., Chen, P., Yen, C., Shen, M., Chen, C., Tsai, K., et al. (2021) Memantine Protects against Paclitaxel-Induced Cognitive Impairment through Modulation of Neurogenesis and Inflammation in Mice. Cancers, 13, Article 4177. >https://doi.org/10.3390/cancers13164177
Nakamura, Z.M., Deal, A.M., Park, E.M., Stanton, K.E., Lopez, Y.E., Quillen, L.J., et al. (2023) A Phase II Single-Arm Trial of Memantine for Prevention of Cognitive Decline during Chemotherapy in Patients with Early Breast Cancer: Feasibility, Tolerability, Acceptability, and Preliminary Effects. Cancer Medicine, 12, 8172-8183. >https://doi.org/10.1002/cam4.5619
Mar Fan, H.G., Clemons, M., Xu, W., Chemerynsky, I., Breunis, H., Braganza, S., et al. (2007) A Randomized, Placebo-Controlled, Double-Blind Trial of the Effects of D-Methylphenidate on Fatigue and Cognitive Dysfunction in Women Undergoing Adjuvant Chemotherapy for Breast Cancer. Supportive Care in Cancer, 16, 577-583. >https://doi.org/10.1007/s00520-007-0341-9
Kohli, S., Fisher, S.G., Tra, Y., Adams, M.J., Mapstone, M.E., Wesnes, K.A., et al. (2009) The Effect of Modafinil on Cognitive Function in Breast Cancer Survivors. Cancer, 115, 2605-2616. >https://doi.org/10.1002/cncr.24287
Attia, A., Rapp, S.R., Case, L.D., D’Agostino, R., Lesser, G., Naughton, M., et al. (2012) Phase II Study of Ginkgo Biloba in Irradiated Brain Tumor Patients: Effect on Cognitive Function, Quality of Life, and Mood. Journal of Neuro-Oncology, 109, 357-363. >https://doi.org/10.1007/s11060-012-0901-9
Barton, D.L., Burger, K., Novotny, P.J., Fitch, T.R., Kohli, S., Soori, G., et al. (2012) The Use of Ginkgo Biloba for the Prevention of Chemotherapy-Related Cognitive Dysfunction in Women Receiving Adjuvant Treatment for Breast Cancer, N00c9. Supportive Care in Cancer, 21, 1185-1192. >https://doi.org/10.1007/s00520-012-1647-9
Palmer, A.C.S., Zortea, M., Souza, A., Santos, V., Biazús, J.V., Torres, I.L.S., et al. (2020) Clinical Impact of Melatonin on Breast Cancer Patients Undergoing Chemotherapy; Effects on Cognition, Sleep and Depressive Symptoms: A Randomized, Double-Blind, Placebo-Controlled Trial. PLOS ONE, 15, e0231379. >https://doi.org/10.1371/journal.pone.0231379
罗璠, 张晨阳, 袁梦琪, 等. 李佩文从“脏神-脑神”辨治乳腺癌化疗相关认知障碍经验[J]. 中医药导报, 2023, 29(11): 183-185+192.
陈佳静, 刘胜, 秦悦农, 等. 乳腺术后三阴方干预三阴性乳腺癌化疗脑症状临床研究[J]. 世界中医药, 2024, 19(5): 666-671.
Chan, R.J., McCarthy, A.L., Devenish, J., Sullivan, K.A. and Chan, A. (2015) Systematic Review of Pharmacologic and Non-Pharmacologic Interventions to Manage Cognitive Alterations after Chemotherapy for Breast Cancer. European Journal of Cancer, 51, 437-450. >https://doi.org/10.1016/j.ejca.2014.12.017
Dos Santos, M., Hardy-Léger, I., Rigal, O., Licaj, I., Dauchy, S., Levy, C., et al. (2020) Cognitive Rehabilitation Program to Improve Cognition of Cancer Patients Treated with Chemotherapy: A 3-Arm Randomized Trial. Cancer, 126, 5328-5336. >https://doi.org/10.1002/cncr.33186
Zeng, Y., Dong, J., Huang, M., Zhang, J., Zhang, X., Xie, M., et al. (2020) Nonpharmacological Interventions for Cancer-Related Cognitive Impairment in Adult Cancer Patients: A Network Meta-Analysis. International Journal of Nursing Studies, 104, Article 103514. >https://doi.org/10.1016/j.ijnurstu.2019.103514
Liu, Y., Liu, J., Chen, S., Zhao, F., Chen, L. and Li, R. (2022) Effectiveness of Nonpharmacologic Interventions for Chemotherapy-Related Cognitive Impairment in Breast Cancer Patients. Cancer Nursing, 46, E305-E319. >https://doi.org/10.1097/ncc.0000000000001152
Reid-Arndt, S.A., Matsuda, S. and Cox, C.R. (2012) Tai Chi Effects on Neuropsychological, Emotional, and Physical Functioning Following Cancer Treatment: A Pilot Study. Complementary Therapies in Clinical Practice, 18, 26-30. >https://doi.org/10.1016/j.ctcp.2011.02.005
Oberste, M., Schaffrath, N., Schmidt, K., Bloch, W., Jäger, E., Steindorf, K., et al. (2018) Protocol for the “Chemobrain in Motion Study” (CIM-Study): A Randomized Placebo-Controlled Trial of the Impact of a High-Intensity Interval Endurance Training on Cancer Related Cognitive Impairments in Women with Breast Cancer Receiving First-Line Chemotherapy. BMC Cancer, 18, Article No. 1071. >https://doi.org/10.1186/s12885-018-4992-3
Kiesl, D., Kuzdas-Sallaberger, M., Fuchs, D., Brunner, S., Kommenda, R., Tischler, C., et al. (2022) Protocol for the Exercise, Cancer and Cognition—The Ecco-Study: A Randomized Controlled Trial of Simultaneous Exercise during Neo-/Adjuvant Chemotherapy in Breast Cancer Patients and Its Effects on Neurocognition. Frontiers in Neurology, 13, Article 777808. >https://doi.org/10.3389/fneur.2022.777808
Koevoets, E.W., Schagen, S.B., de Ruiter, M.B., et al. (2022) Effect of Physical Exercise on Cognitive Function after Chemotherapy in Patients with Breast Cancer: A Randomized Controlled Trial (PAM Study). Breast Cancer Research, 24, Article No. 36.
魏小林. 八段锦对化疗期乳腺癌患者认知功能及生活质量的干预效果研究[D]: [硕士学位论文]. 上海: 上海中医药大学, 2021.
Reich, R.R., Lengacher, C.A., Alinat, C.B., Kip, K.E., Paterson, C., Ramesar, S., et al. (2017) Mindfulness-Based Stress Reduction in Post-Treatment Breast Cancer Patients: Immediate and Sustained Effects across Multiple Symptom Clusters. Journal of Pain and Symptom Management, 53, 85-95. >https://doi.org/10.1016/j.jpainsymman.2016.08.005
Lengacher, C.A., Reich, R.R., Paterson, C.L., Ramesar, S., Park, J.Y., Alinat, C., et al. (2016) Examination of Broad Symptom Improvement Resulting from Mindfulness-Based Stress Reduction in Breast Cancer Survivors: A Randomized Controlled Trial. Journal of Clinical Oncology, 34, 2827-2834. >https://doi.org/10.1200/jco.2015.65.7874
Lin, J.G., Kotha, P. and Chen, Y.H. (2022) Understandings of Acupuncture Application and Mechanisms. American Journal of Translational Research, 14, 1469-1481.
Zhang, Z., Man, S., Yam, L., Yiu, C.Y., Leung, R.C., Qin, Z., et al. (2020) Electroacupuncture Trigeminal Nerve Stimulation Plus Body Acupuncture for Chemotherapy-Induced Cognitive Impairment in Breast Cancer Patients: An Assessor-Participant Blinded, Randomized Controlled Trial. Brain, Behavior, and Immunity, 88, 88-96. >https://doi.org/10.1016/j.bbi.2020.04.035
Zeng, Y., Cheng, A.S.K., Song, T., Sheng, X., Wang, S., Xie, J., et al. (2018) Effects of Acupuncture on Cancer-Related Cognitive Impairment in Chinese Gynecological Cancer Patients: A Pilot Cohort Study. Integrative Cancer Therapies, 17, 737-746. >https://doi.org/10.1177/1534735418777109